MedCity News March 24, 2024
Marissa Plescia

A new report from the Peterson Health Technology Institute analyzed eight digital diabetes management tools. It found that the tools don’t provide meaningful clinical benefits and increase healthcare spending.

Digital diabetes management tools fail to provide meaningful clinical benefits and increase health spending, a new report from the Peterson Health Technology Institute (PHTI) shows.

This is PHTI’s inaugural report after launching in July as an independent evaluator of digital health solutions. The analysis evaluated eight digital tools that support people with type 2 diabetes: DarioHealth, Glooko, Omada, Perry Health, Teladoc’s Livongo, Verily’s Onduo, Vida, and Virta. These solutions use three approaches:

  • Remote patient monitoring (Glooko)
  • Behavior and lifestyle modification (DarioHealth, Omada, Perry Health, Livongo, Onduo and Vida)
  • Nutritional...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Apps, Digital Health, Patient / Consumer, Provider, Survey / Study, Technology, Trends
Related Articles:
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
Telehealth gets short extension, physician pay is cut in spending bill
Sweat BioSensors: Emerging HealthTech market to watch in 2025
Amazon One Medical: the beginning of a text-based TeleHealth revolution?
Congress Extends Hospice Telehealth Flexibilities

Share This Article